ClinicalTrials.govpublic full text
Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF
diabetes mellitus, type 2, heart failure with preserved ejection fraction, diabetes mellitus, heart failure, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807271
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.